Literature DB >> 12003828

Heart size-independent analysis of myocardial function in murine pressure overload hypertrophy.

Hideyuki Takaoka1, Giovanni Esposito, Lan Mao, Hiroyuki Suga, Howard A Rockman.   

Abstract

Pressure overload cardiac hypertrophy may be a compensatory mechanism to normalize systolic wall stress and preserve left ventricular (LV) function. To test this concept, we developed a novel in vivo method to measure myocardial stress (sigma)-strain (epsilon) relations in normal and hypertrophied mice. LV volume was measured using two pairs of miniature omnidirectional piezoelectric crystals implanted orthogonally in the endocardium and one crystal placed on the anterior free wall to measure instantaneous wall thickness. Highly linear sigma-epsilon relations were obtained in control (n = 7) and hypertrophied mice produced by 7 days of transverse aortic constriction (TAC; n = 13). Administration of dobutamine in control mice significantly increased the load-independent measure of LV contractility, systolic myocardial stiffness. In TAC mice, systolic myocardial stiffness was significantly greater than in control mice (3,156 +/- 1,433 vs. 1,435 +/- 467 g/cm(2), P < 0.01), indicating enhanced myocardial contractility with pressure overload. However, despite the increased systolic performance, both active (time constant of LV pressure decay) and passive (diastolic myocardial stiffness constant) diastolic properties were markedly abnormal in TAC mice compared with control mice. These data suggest that the development of cardiac hypertrophy is associated with a heightened contractile state, perhaps as an early compensatory response to pressure overload.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003828     DOI: 10.1152/ajpheart.00759.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  6 in total

1.  Arterial haemodynamics on ventricular hypertrophy in rats with simulated aortic stiffness.

Authors:  Hsing I Chen; Nan-Kuang Hsieh; Huai-Ren Chang; Cheng-Tao Hu
Journal:  Pflugers Arch       Date:  2007-09-15       Impact factor: 3.657

2.  ATF6 Regulates Cardiac Hypertrophy by Transcriptional Induction of the mTORC1 Activator, Rheb.

Authors:  Erik A Blackwood; Christoph Hofmann; Michelle Santo Domingo; Alina S Bilal; Anup Sarakki; Winston Stauffer; Adrian Arrieta; Donna J Thuerauf; Fred W Kolkhorst; Oliver J Müller; Tobias Jakobi; Christoph Dieterich; Hugo A Katus; Shirin Doroudgar; Christopher C Glembotski
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

3.  Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice.

Authors:  Stephane Heymans; Florea Lupu; Sven Terclavers; Bjorn Vanwetswinkel; Jean-Marc Herbert; Andrew Baker; Desire Collen; Peter Carmeliet; Lieve Moons
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

4.  Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction.

Authors:  Cinzia Perrino; Sathyamangla V Naga Prasad; Lan Mao; Takahisa Noma; Zhen Yan; Hyung-Suk Kim; Oliver Smithies; Howard A Rockman
Journal:  J Clin Invest       Date:  2006-06       Impact factor: 14.808

5.  Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene.

Authors:  Kathleen M I Caron; Leighton R James; Hyung-Suk Kim; Josh Knowles; Rick Uhlir; Lan Mao; John R Hagaman; Wayne Cascio; Howard Rockman; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

Review 6.  Biomaterial strategies for alleviation of myocardial infarction.

Authors:  Jayarama Reddy Venugopal; Molamma P Prabhakaran; Shayanti Mukherjee; Rajeswari Ravichandran; Kai Dan; Seeram Ramakrishna
Journal:  J R Soc Interface       Date:  2011-09-07       Impact factor: 4.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.